The response to the COVID-19 pandemic trusted in pharmacovigilance to diminish communication risk

Producción científica: Contribución a una revista › Editorial › revisión exhaustiva

Idioma original	Inglés estadounidense
Páginas (desde-hasta)	1-3
Número de páginas	3
Publicación	Therapeutic Advances in Drug Safety
Volumen	13
DOI	https://doi.org/10.1177/20420986221088650
Estado	Publicada - mar. 2022

Áreas temáticas de ASJC Scopus

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

@article{68ed39d3a0e5402a8402c6011f2daee6,

title = "The response to the COVID-19 pandemic trusted in pharmacovigilance to diminish communication risk",

author = "Quintero, {Gustavo A.}",

note = "Funding Information: The author received no financial support for the research, authorship, and/or publication of this article.",

year = "2022",

month = mar,

doi = "10.1177/20420986221088650",

language = "English (US)",

volume = "13",

pages = "1--3",

journal = "Therapeutic Advances in Drug Safety",

issn = "2042-0986",

publisher = "SAGE Publications Ltd",

}

TY - JOUR

T1 - The response to the COVID-19 pandemic trusted in pharmacovigilance to diminish communication risk

AU - Quintero, Gustavo A.

N1 - Funding Information: The author received no financial support for the research, authorship, and/or publication of this article.

PY - 2022/3

Y1 - 2022/3

UR - http://www.scopus.com/inward/record.url?scp=85128193350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85128193350&partnerID=8YFLogxK

U2 - 10.1177/20420986221088650

DO - 10.1177/20420986221088650

M3 - Editorial

C2 - 35369126

AN - SCOPUS:85128193350

SN - 2042-0986

VL - 13

SP - 1

EP - 3

JO - Therapeutic Advances in Drug Safety

JF - Therapeutic Advances in Drug Safety

ER -